Jones, N. R., Smith, M. ., Lay-Flurrie, S. ., Yang, Y. ., Hobbs, F. R., & Taylor, C. J. (2024). Heart failure and major haemorrhage in people with atrial fibrillation. Open Heart, 11. http://doi.org/10.1136/openhrt-2024-002975
anticoagulation
Ajabnoor, A. M., Parisi, R. ., Zghebi, S. S., Ashcroft, D. M., Faivre-Finn, C. ., Morris, C. ., … Kontopantelis, E. . (2023). Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England, 2009-2019. Cancer. http://doi.org/10.1002/cncr.35152
Apenteng, P. N., Prieto-Merino, D. ., Hee, S. W., Lobban, T. C., Caleyachetty, R. ., & Fitzmaurice, D. A. (2023). Optimising prediction of mortality, stroke, and major bleeding for patients with atrial fibrillation: validation of the GARFIELD-AF tool in UK primary care electronic records. Br J Gen Pract, 73, e816-e824. http://doi.org/10.3399/bjgp.2023.0082
Mendonca, S. C., Edwards, D. A., Lund, J. ., Saunders, C. L., & Mant, J. . (2023). Progression of stroke risk in patients aged <65 years diagnosed with atrial fibrillation: a cohort study in general practice. Br J Gen Pract. http://doi.org/10.3399/bjgp.2022.0568
Hunt, N. B., Pajouheshnia, R. ., Salih, A. ., van Doorn, S. ., Souverein, P. C., Bazelier, M. T., … Gardarsdottir, H. . (2023). Prescribing of Low-dose Rivaroxaban in Patients with Atherosclerotic Cardiovascular Disease in the United Kingdom and the Netherlands. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.15708
van den Dries, C. J., Pajouheshnia, R. ., van den Ham, H. A., Souverein, P. ., Moons, K. G. M., Hoes, A. W., … van Doorn, S. . (2022). Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.15534